BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19422391)

  • 1. The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms.
    Spitzmaul G; Gumilar F; Dilger JP; Bouzat C
    Br J Pharmacol; 2009 Jul; 157(5):804-17. PubMed ID: 19422391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.
    Gumilar F; Arias HR; Spitzmaul G; Bouzat C
    Neuropharmacology; 2003 Dec; 45(7):964-76. PubMed ID: 14573389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Gumilar F; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW; Bouzat C
    Biochemistry; 2009 Jun; 48(21):4506-18. PubMed ID: 19334677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctions in agonist and antagonist specificity conferred by anionic residues of the nicotinic acetylcholine receptor.
    Osaka H; Sugiyama N; Taylor P
    J Biol Chem; 1998 May; 273(21):12758-65. PubMed ID: 9582301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ.
    Eterović VA; Lu R; Eakin AE; Rodríguez AD; Ferchmin PA
    Cell Mol Neurobiol; 1999 Dec; 19(6):745-57. PubMed ID: 10456235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
    Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
    Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conformational intermediate between the resting and desensitized states of the nicotinic acetylcholine receptor.
    Ryan SE; Blanton MP; Baenziger JE
    J Biol Chem; 2001 Feb; 276(7):4796-803. PubMed ID: 11083863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
    Gumilar F; Bouzat C
    Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local anaesthetic blockade of neuronal nicotinic ACh receptor-channels in rat parasympathetic ganglion cells.
    Cuevas J; Adams DJ
    Br J Pharmacol; 1994 Mar; 111(3):663-72. PubMed ID: 7517326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding channel blocking in the nicotinic acetylcholine receptor.
    Ortells MO; Barrantes GE
    Recept Channels; 2001; 7(4):273-88. PubMed ID: 11697233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
    García-Colunga J; Miledi R
    Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding sites contribute unequally to the gating of mouse nicotinic alpha D200N acetylcholine receptors.
    Akk G; Sine S; Auerbach A
    J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):185-96. PubMed ID: 8910207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes.
    Gentry CL; Lukas RJ
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1038-48. PubMed ID: 11714893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of membrane-bound Torpedo acetylcholine receptor by amine noncompetitive antagonists and aliphatic alcohols: studies of [3H]acetylcholine binding and 22Na+ ion fluxes.
    Boyd ND; Cohen JB
    Biochemistry; 1984 Aug; 23(18):4023-33. PubMed ID: 6091734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.
    Heiny JA; Kravtsova VV; Mandel F; Radzyukevich TL; Benziane B; Prokofiev AV; Pedersen SE; Chibalin AV; Krivoi II
    J Biol Chem; 2010 Sep; 285(37):28614-26. PubMed ID: 20595385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.